Nanoparticle technology for delivery of drugs across the blood-brain barrier

Journal of Pharmaceutical Sciences

Volumn 87, Issue 11, 1998, Pages 1305-1307

  Schroeder, Ulrike ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; LEUCINE ENKEPHALIN; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; METENKEPHALIN; NANOPARTICLE; POLYSORBATE;

ADSORPTION; ANALGESIA; ANIMAL CELL; BLOOD BRAIN BARRIER; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; GAS CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; POLYMERIZATION; PROTEIN TRANSPORT; TECHNOLOGY;

EID: 0031765572     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980084y     Document Type: Conference Paper

References (21)

1. Rapoport, S. I. Modulation of blood-brain barrier permeability. J. Drug Target. 1996, 3, 417-425.
2. Tamai, I.; Tsuji, A. Drug delivery through the blood-brain barrier. Adv. Drug Del. Rev. 1996, 19, 401-424.
3. Banks, W. A,; Kastin, A. J.; Barrera, C. M. Delivering peptides to the central nervous system: Dilemmas and strategies. Pharm. Res. 1991, 8, 1345-1350.
4. Banks, W. A.; Kastin, A. J. Reversible association of the cytokines MIP-la and MIP-1/3 with the endothelia of the blood-brain barrier. Neurosci. Lett. 1996, 205, 202-206.
5. Plotkin, S. R.; Banks, W. A.; Kastin, A. J. Comparison of saturable transport and extracellular pathways in the passage of interleukin-la across the blood-brain barrier. J. Neuroimmunol. 1996, 67, 41-47.
6. Hiesiger, E. M.; Voorhies, R. M.; Basler, G. A.; Lipschutz, L. E.; Posner, J. B.; Sharpio, W. R. Opening the blood-brain and blood-tumor barriers in experimental rat tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Ann. Neural. 1986, 19, 50-59.
7. Abbott, N. J.; Revest, P. A. Control of brain endothelial permeability. Cerebrovasc. Brain Metab. Rev. 1991, 3, 3972.
8. Greenwood, J. Experimental manipulation of the blood-brain and blood-retinal barriers. In Physiology and Pharmacology of the Blood-Brain Barrier. Handbook of Experimental Pharmacology; Bradbury, M. W. B.; Abbott, N. J., Eds.; Springer-Verlag: Berlin, 1992; pp 459-486.
9. Zhou, X.; Huang, L. Targeted delivery of DANN by liposomes and polymers. J. Controlled Release 1992, 19, 269-274.
10. Borchardt, G.; Kenneth, L. A.; Fenlin, S.; Kreuter, J. Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers. Int. J. Pharmacol. 1994, 110, 29-35.
11. Kreuter, J.; Alyautdin, R. N.; Kharkevich, D.; Ivanov, A. A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 1995, 674, 171-174.
12. Tröster, S. D.; Müller, U.; Kreuter, J. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int. J. Pharm. 1990, 61, 85-100.
13. Kalenikova, E. L; Dmitrieva, O. F.; Korobov, N. N.; Zhukova, S. V.; Tischenko, V. A. Farmakokinetika dalargina. Vopr. Med. Khim. 1988, 34, 75-83.
14. Takagi, H.; Shiomi, Y.; Ueda, H. Analgesic dipeptide, L-TyrD-Arg(D-Kyotorphin) induced Met-enkephalin release from guinea-pig striatal slices. Experientia 1982, 38, 13441345.
15. Kreuter, J. Evaluation of nanoparticles as drug-delivery systems. I. Preparations methods. Pharm. Acta Helv. 1983, 58, 196-209.
16. Schroeder, U.; Sommerfeld, P.; Sabel, B. A. Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides, 1998, 19, 777-780.
17. Ulrich, S.; Isensee, T.; Pester, U. Simultaneous determination of amitriptyline, nortriptyline and 4 hydroxylated metabolites in serum by capillary gas-liquid chromatography with nitrogen-phosphorus selective detection. J. Chromatogr. B. 1996, 685, 81-89.
18. Alyautdin, R.; Gothier, D.; Petrov, V.; Kharkevich, D.; Kreuter, J. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butylcyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 1995, 41, 44-48.
19. Schröder, U.; Sabel, B. A. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res. 1996, 770, 121-124.
20. Lee, K. H.; Chai, C. Y.; Wayner, M. J.; Chung, P. M.; Hsu, C. H. Effects of neuroleptics on morphine-induced tail erection in mice. Pharmacol. Biochem. Behav. 1977, 7, 153157.
21. Lenaerts, V.; Couvreur, P.; Christiaens-Leyh, D.; Joins, E.; Roland, M.; Rollmann, B.; Speiser, P. Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials 1984, 5, 65-78.